SCHEMBL30945699

SCHEMBL30945699

Cc1ccc2c(c1)C1CN(C)CCC1N2C(=O)/C(=C/c1ccc(Cl)cc1)c1ccc(F)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.62
▸ LMNA P02545 2/20 0.62
▸ TSHR P16473 1/20 0.62
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ CYP1A2 P05177 2/20 0.53
▸ CYP2D6 P10635 2/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ MCL1 Q07820 1/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ KDM4E B2RXH2 2/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ CYP3A4 P08684 1/20 0.50
▸ F2 P00734 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12868685 0.81 ALDH1A1 (0.65) MAPTLMNATSHRMEN1KMT2A
SCHEMBL30945708 0.79 SMN1; SMN2 (0.73) MAPTLMNATSHRMEN1KMT2A
SCHEMBL12882736 0.77 MAPT (0.81) MAPTLMNATSHRMEN1KMT2A
SCHEMBL10127900 0.77 MAPT (0.66) MAPTLMNATSHRMEN1KMT2A
SCHEMBL12868618 0.74 ALDH1A1 (0.65) MAPTLMNATSHRMEN1KMT2A
SCHEMBL29223991 0.74 ALDH1A1 (0.67) MAPTLMNATSHRMEN1KMT2A
SCHEMBL12868628 0.72 ALDH1A1 (0.62) MAPTLMNATSHRMEN1KMT2A
SCHEMBL12868656 0.72 ALDH1A1 (0.62) MAPTLMNATSHRMEN1KMT2A
SCHEMBL12868271 0.72 LMNA (0.59) MAPTLMNATSHRMEN1KMT2A
SCHEMBL30945667 0.72 ALDH1A1 (0.64) MAPTLMNATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS CULLGEN (SHANGHAI), INC. (CN) 2024-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS DCAF1, DDB1, CUL4A MAPT 1398/4885LMNA 2501/4885TSHR 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback